Now we know what he slips in his coffee every morning... :maduro-coffee:

  • emizeko [they/them]
    ·
    edit-2
    3 years ago

    why are you reposting an article from January, because you couldn't find anything more recent? and why did you use a misleading title?

    • LoMeinTenants [any]
      hexagon
      ·
      3 years ago

      It's the dunk tank, not news. I'm glad it took you 10 comments to finally read the article instead of gesticulating from the tortoise shell.

      • emizeko [they/them]
        ·
        3 years ago

        you didn't even notice that it was from January :michael-laugh:

        • LoMeinTenants [any]
          hexagon
          ·
          3 years ago

          What’s your actual take on this Maduro Carvativir thing?

            • LoMeinTenants [any]
              hexagon
              ·
              3 years ago

              Grim take. The US and its sanctions are working to destroy the Venezuelan people, but stanning bad science costs lives too. Do better, please.

    • LoMeinTenants [any]
      hexagon
      ·
      3 years ago

      What’s your actual take on this Maduro Carvativir thing?

      • thisismyrealname [he/him]
        ·
        3 years ago

        my take is that who gives a shit if Maduro's hawking thyme oil or whatever, still 10000% better than whatever slug person the US wants to put in charge of Venezuela

        • RedHungarian [he/him]
          ·
          3 years ago

          Venezuela’s National Academy of Medicine in a statement late on Monday said Carvativir “has therapeutic potential against coronavirus.”

          “Nonetheless, it is prudent to wait for more data from the Carvativir tests ... to consider it a candidate for an anti-COVID-19 medication,” reads the statement.

          Maduro was far too enthusiastic about an experimental treatment, so now we need to cancel him and PSUV (the only socialist organization of any significance in Venezuela) and join the right-wing opposition in amplifying attacks against a US regime change target.